866-997-4948(US-Canada Toll Free)

China Non Alcoholic Fatty Liver Disease Market Research Report 2017

Published By :

QYResearch

Published Date : Mar 2017

Category :

Pharmaceutical

No. of Pages : 124 Pages

Notes:
Sales, means the sales volume of Non Alcoholic Fatty Liver Disease
Revenue, means the sales value of Non Alcoholic Fatty Liver Disease

This report studies Non Alcoholic Fatty Liver Disease in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
Conatus Pharmaceuticals
Daewoong Pharmaceutical
Galmed International
Kyorin Pharmaceutical
Metabolic Solutions Development
Novartis AG
Phenex Pharmaceuticals
Raptor Pharmaceuticals
TCM Biotech International
Tobira Therapeutics
Verva Pharmaceuticals
Zafgen

Market Segment by Regions (provinces), covering
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China
Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
Insulin Sensitizers
Statins
Pentoxifylline
Others
Split by Application, this report focuses on consumption, market share and growth rate of Non Alcoholic Fatty Liver Disease in each application, can be divided into
Pediatric?
Adults

Table of Contents

China Non Alcoholic Fatty Liver Disease Market Research Report 2017
1 Non Alcoholic Fatty Liver Disease Market Overview
1.1 Product Overview and Scope of Non Alcoholic Fatty Liver Disease
1.2 Non Alcoholic Fatty Liver Disease Segment by Type
1.2.1 China Production Market Share of Non Alcoholic Fatty Liver Disease Type in 2015
1.2.2 Insulin Sensitizers
1.2.3 Statins
1.2.4 Pentoxifylline
1.2.5 Others
1.3 Applications of Non Alcoholic Fatty Liver Disease
1.3.1 Non Alcoholic Fatty Liver Disease Consumption Market Share by Application in 2015
1.3.2 Pediatric?
1.3.3 Adults
1.4 China Market Size (Value) of Non Alcoholic Fatty Liver Disease (2012-2022)
1.5 China Non Alcoholic Fatty Liver Disease Status and Outlook
1.6 Government Policies

2 China Non Alcoholic Fatty Liver Disease Market Competition by Manufacturers
2.1 China Non Alcoholic Fatty Liver Disease Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Non Alcoholic Fatty Liver Disease Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Non Alcoholic Fatty Liver Disease Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Non Alcoholic Fatty Liver Disease Manufacturing Base Distribution, Sales Area, Product Type
2.5 Non Alcoholic Fatty Liver Disease Market Competitive Situation and Trends
2.5.1 Non Alcoholic Fatty Liver Disease Market Concentration Rate
2.5.2 Non Alcoholic Fatty Liver Disease Market Share of Top 3 and Top 5 Manufacturers

3 China Non Alcoholic Fatty Liver Disease Manufacturers Profiles/Analysis
3.1 Conatus Pharmaceuticals
3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.1.2 Non Alcoholic Fatty Liver Disease Product Type, Application and Specification
3.1.2.1 Insulin Sensitizers
3.1.2.2 Statins
3.1.3 Conatus Pharmaceuticals Non Alcoholic Fatty Liver Disease Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.1.4 Main Business/Business Overview
3.2 Daewoong Pharmaceutical
3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.2.2 Non Alcoholic Fatty Liver Disease Product Type, Application and Specification
3.2.2.1 Insulin Sensitizers
3.2.2.2 Statins
3.2.3 Daewoong Pharmaceutical 124 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.2.4 Main Business/Business Overview
3.3 Galmed International
3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.3.2 Non Alcoholic Fatty Liver Disease Product Type, Application and Specification
3.3.2.1 Insulin Sensitizers
3.3.2.2 Statins
3.3.3 Galmed International 129 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.3.4 Main Business/Business Overview
3.4 Kyorin Pharmaceutical
3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.4.2 Non Alcoholic Fatty Liver Disease Product Type, Application and Specification
3.4.2.1 Insulin Sensitizers
3.4.2.2 Statins
3.4.3 Kyorin Pharmaceutical Jan Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.4.4 Main Business/Business Overview
3.5 Metabolic Solutions Development
3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.5.2 Non Alcoholic Fatty Liver Disease Product Type, Application and Specification
3.5.2.1 Insulin Sensitizers
3.5.2.2 Statins
3.5.3 Metabolic Solutions Development Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.5.4 Main Business/Business Overview
3.6 Novartis AG
3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.6.2 Non Alcoholic Fatty Liver Disease Product Type, Application and Specification
3.6.2.1 Insulin Sensitizers
3.6.2.2 Statins
3.6.3 Novartis AG Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.6.4 Main Business/Business Overview
3.7 Phenex Pharmaceuticals
3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.7.2 Non Alcoholic Fatty Liver Disease Product Type, Application and Specification
3.7.2.1 Insulin Sensitizers
3.7.2.2 Statins
3.7.3 Phenex Pharmaceuticals Pharma & Healthcare Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.7.4 Main Business/Business Overview
3.8 Raptor Pharmaceuticals
3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.8.2 Non Alcoholic Fatty Liver Disease Product Type, Application and Specification
3.8.2.1 Insulin Sensitizers
3.8.2.2 Statins
3.8.3 Raptor Pharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.8.4 Main Business/Business Overview
3.9 TCM Biotech International
3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.9.2 Non Alcoholic Fatty Liver Disease Product Type, Application and Specification
3.9.2.1 Insulin Sensitizers
3.9.2.2 Statins
3.9.3 TCM Biotech International Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.9.4 Main Business/Business Overview
3.10 Tobira Therapeutics
3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.10.2 Non Alcoholic Fatty Liver Disease Product Type, Application and Specification
3.10.2.1 Insulin Sensitizers
3.10.2.2 Statins
3.10.3 Tobira Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.10.4 Main Business/Business Overview
3.11 Verva Pharmaceuticals
3.12 Zafgen

4 China Non Alcoholic Fatty Liver Disease Capacity, Production, Revenue, Consumption, Export and Import (2012-2017)
4.1 China Non Alcoholic Fatty Liver Disease Capacity, Production and Growth (2012-2017)
4.2 China Non Alcoholic Fatty Liver Disease Revenue and Growth (2012-2017)
4.3 China Non Alcoholic Fatty Liver Disease Production, Consumption, Export and Import (2012-2017)

5 China Non Alcoholic Fatty Liver Disease Production, Revenue (Value), Price Trend by Type
5.1 China Non Alcoholic Fatty Liver Disease Production and Market Share by Type (2012-2017)
5.2 China Non Alcoholic Fatty Liver Disease Revenue and Market Share by Type (2012-2017)
5.3 China Non Alcoholic Fatty Liver Disease Price by Type (2012-2017)
5.4 China Non Alcoholic Fatty Liver Disease Production Growth by Type (2012-2017)

6 China Non Alcoholic Fatty Liver Disease Market Analysis by Application
6.1 China Non Alcoholic Fatty Liver Disease Consumption and Market Share by Application (2012-2017)
6.2 China Non Alcoholic Fatty Liver Disease Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Application
6.3.2 Emerging Markets/Countries

7 ChinaNon Alcoholic Fatty Liver Disease Market Analysis by Regions (Provinces)
7.1 China Non Alcoholic Fatty Liver Disease Production, Production Value and Price by Regions (Provinces)(2012-2017)
7.1.1 China Non Alcoholic Fatty Liver Disease Production and Market Share by Regions (Provinces)(2012-2017)
7.1.2 China Non Alcoholic Fatty Liver Disease Production Value and Market Share by Regions (Provinces)(2012-2017)
7.1.3 China Non Alcoholic Fatty Liver Disease Sales Price by Regions (Provinces)(2012-2017)
7.2 China Non Alcoholic Fatty Liver Disease Consumption by Regions (Provinces)(2012-2017)
7.3 China Non Alcoholic Fatty Liver Disease Production, Consumption, Export and Import (2012-2017)

8 Non Alcoholic Fatty Liver Disease Manufacturing Cost Analysis
8.1 Non Alcoholic Fatty Liver Disease Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Non Alcoholic Fatty Liver Disease

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Non Alcoholic Fatty Liver Disease Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Non Alcoholic Fatty Liver Disease Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 China Non Alcoholic Fatty Liver Disease Market Forecast (2017-2022)
12.1 China Non Alcoholic Fatty Liver Disease Capacity, Production, Revenue Forecast (2017-2022)
12.2 China Non Alcoholic Fatty Liver Disease Production, Import, Export and Consumption Forecast (2017-2022)
12.3 China Non Alcoholic Fatty Liver Disease Production Forecast by Type (2017-2022)
12.4 China Non Alcoholic Fatty Liver Disease Consumption Forecast by Application (2017-2022)
12.5 China Non Alcoholic Fatty Liver Disease Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.5.1 China Non Alcoholic Fatty Liver Disease Production Forecast by Regions (Provinces)(2017-2022)
12.5.2 China Non Alcoholic Fatty Liver Disease Consumption Forecast by Regions (Provinces)(2017-2022)
12.5.3 China Non Alcoholic Fatty Liver Disease Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.6 Non Alcoholic Fatty Liver Disease Price Forecast (2017-2022)

13 Research Findings and Conclusion

14 Appendix
Methodology
Analyst Introduction
Data Source


List of Table

List of Tables and Figures

Figure Picture of Non Alcoholic Fatty Liver Disease
Figure China Production Market Share of Non Alcoholic Fatty Liver Disease by Type in 2015
Figure Product Picture of Insulin Sensitizers
Table Major Manufacturers of Insulin Sensitizers
Figure Product Picture of Statins
Table Major Manufacturers of Statins
Figure Product Picture of Pentoxifylline
Table Major Manufacturers of Pentoxifylline
Figure Product Picture of Others
Table Major Manufacturers of Others
Table Non Alcoholic Fatty Liver Disease Consumption Market Share by Application in 2015
Figure Pediatric? Examples
Figure Adults Examples
Figure China Non Alcoholic Fatty Liver Disease Revenue (Million USD) and Growth Rate (2012-2022)
Table China Non Alcoholic Fatty Liver Disease Capacity of Key Manufacturers (2015 and 2016)
Table China Non Alcoholic Fatty Liver Disease Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Non Alcoholic Fatty Liver Disease Capacity of Key Manufacturers in 2015
Figure China Non Alcoholic Fatty Liver Disease Capacity of Key Manufacturers in 2016
Table China Non Alcoholic Fatty Liver Disease Production of Key Manufacturers (2015 and 2016)
Table China Non Alcoholic Fatty Liver Disease Production Share by Manufacturers (2015 and 2016)
Figure 2015 Non Alcoholic Fatty Liver Disease Production Share by Manufacturers
Figure 2016 Non Alcoholic Fatty Liver Disease Production Share by Manufacturers
Table China Non Alcoholic Fatty Liver Disease Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Non Alcoholic Fatty Liver Disease Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Non Alcoholic Fatty Liver Disease Revenue Share by Manufacturers
Table 2016 China Non Alcoholic Fatty Liver Disease Revenue Share by Manufacturers
Table China Market Non Alcoholic Fatty Liver Disease Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Non Alcoholic Fatty Liver Disease Average Price of Key Manufacturers in 2015
Table Manufacturers Non Alcoholic Fatty Liver Disease Manufacturing Base Distribution and Sales Area
Table Manufacturers Non Alcoholic Fatty Liver Disease Product Type
Figure Non Alcoholic Fatty Liver Disease Market Share of Top 3 Manufacturers
Figure Non Alcoholic Fatty Liver Disease Market Share of Top 5 Manufacturers
Table Conatus Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Conatus Pharmaceuticals Non Alcoholic Fatty Liver Disease Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Conatus Pharmaceuticals Non Alcoholic Fatty Liver Disease Market Share (2012-2017)
Table Daewoong Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Daewoong Pharmaceutical Non Alcoholic Fatty Liver Disease Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Daewoong Pharmaceutical Non Alcoholic Fatty Liver Disease Market Share (2012-2017)
Table Galmed International Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Galmed International Non Alcoholic Fatty Liver Disease Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Galmed International Non Alcoholic Fatty Liver Disease Market Share (2012-2017)
Table Kyorin Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Kyorin Pharmaceutical Non Alcoholic Fatty Liver Disease Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Kyorin Pharmaceutical Non Alcoholic Fatty Liver Disease Market Share (2012-2017)
Table Metabolic Solutions Development Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Metabolic Solutions Development Non Alcoholic Fatty Liver Disease Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Metabolic Solutions Development Non Alcoholic Fatty Liver Disease Market Share (2012-2017)
Table Novartis AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis AG Non Alcoholic Fatty Liver Disease Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis AG Non Alcoholic Fatty Liver Disease Market Share (2012-2017)
Table Phenex Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Phenex Pharmaceuticals Non Alcoholic Fatty Liver Disease Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Phenex Pharmaceuticals Non Alcoholic Fatty Liver Disease Market Share (2012-2017)
Table Raptor Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Raptor Pharmaceuticals Non Alcoholic Fatty Liver Disease Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Raptor Pharmaceuticals Non Alcoholic Fatty Liver Disease Market Share (2012-2017)
Table TCM Biotech International Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table TCM Biotech International Non Alcoholic Fatty Liver Disease Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure TCM Biotech International Non Alcoholic Fatty Liver Disease Market Share (2012-2017)
Table Tobira Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Tobira Therapeutics Non Alcoholic Fatty Liver Disease Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Tobira Therapeutics Non Alcoholic Fatty Liver Disease Market Share (2012-2017)
Table Verva Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Zafgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Figure China Non Alcoholic Fatty Liver Disease Capacity, Production and Growth (2012-2017)
Figure China Non Alcoholic Fatty Liver Disease Revenue (Million USD) and Growth (2012-2017)
Table China Non Alcoholic Fatty Liver Disease Production, Consumption, Export and Import (2012-2017)
Table China Non Alcoholic Fatty Liver Disease Production by Type (2012-2017)
Table China Non Alcoholic Fatty Liver Disease Production Share by Type (2012-2017)
Figure Production Market Share of Non Alcoholic Fatty Liver Disease by Type (2012-2017)
Figure 2015 Production Market Share of Non Alcoholic Fatty Liver Disease by Type
Table China Non Alcoholic Fatty Liver Disease Revenue by Type (2012-2017)
Table China Non Alcoholic Fatty Liver Disease Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Non Alcoholic Fatty Liver Disease by Type (2012-2017)
Figure 2015 Revenue Market Share of Non Alcoholic Fatty Liver Disease by Type
Table China Non Alcoholic Fatty Liver Disease Price by Type (2012-2017)
Figure China Non Alcoholic Fatty Liver Disease Production Growth by Type (2012-2017)
Table China Non Alcoholic Fatty Liver Disease Consumption by Application (2012-2017)
Table China Non Alcoholic Fatty Liver Disease Consumption Market Share by Application (2012-2017)
Figure China Non Alcoholic Fatty Liver Disease Consumption Market Share by Application in 2015
Table China Non Alcoholic Fatty Liver Disease Consumption Growth Rate by Application (2012-2017)
Figure China Non Alcoholic Fatty Liver Disease Consumption Growth Rate by Application (2012-2017)
Table China Non Alcoholic Fatty Liver Disease Production by Regions (Provinces)(2012-2017)
Table China Non Alcoholic Fatty Liver Disease Production Market Share by Regions (Provinces)(2012-2017)
Table China Non Alcoholic Fatty Liver Disease Production Value by Regions (Provinces)(2012-2017)
Table China Non Alcoholic Fatty Liver Disease Production Value Market Share by Regions (Provinces)(2012-2017)
Table China Non Alcoholic Fatty Liver Disease Sales Price by Regions (Provinces)(2012-2017)
Table China Non Alcoholic Fatty Liver Disease Consumption by Regions (Provinces)(2012-2017)
Table China Non Alcoholic Fatty Liver Disease Consumption Market Share by Regions (Provinces)(2012-2017)
Table China Non Alcoholic Fatty Liver Disease Production, Consumption, Export and Import (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Non Alcoholic Fatty Liver Disease
Figure Manufacturing Process Analysis of Non Alcoholic Fatty Liver Disease
Figure Non Alcoholic Fatty Liver Disease Industrial Chain Analysis
Table Raw Materials Sources of Non Alcoholic Fatty Liver Disease Major Manufacturers in 2015
Table Major Buyers of Non Alcoholic Fatty Liver Disease
Table Distributors/Traders List
Figure China Non Alcoholic Fatty Liver Disease Capacity, Production and Growth Rate Forecast (2017-2022)
Figure China Non Alcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2017-2022)
Table China Non Alcoholic Fatty Liver Disease Production, Import, Export and Consumption Forecast (2017-2022)
Table China Non Alcoholic Fatty Liver Disease Production Forecast by Type (2017-2022)
Table China Non Alcoholic Fatty Liver Disease Consumption Forecast by Application (2017-2022)
Table China Non Alcoholic Fatty Liver Disease Production Forecast by Regions (Provinces)(2017-2022)
Table China Non Alcoholic Fatty Liver Disease Consumption Forecast by Regions (Provinces)(2017-2022)
Table China Non Alcoholic Fatty Liver Disease Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *